Showing results (691-700 of 1,120) with videos related to

Sort By:
Pageof 112
Journal of the American Heart Association|August 25, 2017
The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities StudyPaul L Hess, Hussein R Al-Khalidi, Daniel J Friedman, et al.
Diabetes Care|October 16, 2016
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOSJan H Cornel, George L Bakris, Susanna R Stevens, et al.
Respiratory Medicine|April 19, 2026
Long-term Safety of the Pfizer-BioNTech COVID-19 Vaccine: Results from the HERO-Together StudyEmily C O'Brien, Cherise Wong, Jesse M DeLaRosa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2020
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trialRaffaele De Caterina, Giuseppe Patti, Johan Westerbergh, et al.
American Heart Journal|June 7, 2016
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationaleMeena P Rao, Andrea O Ciobanu, Renato D Lopes, et al.
Circulation|December 10, 2015
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV TrialRalf E Harskamp, John H Alexander, T Bruce Ferguson, et al.
The American Journal of Cardiology|July 14, 2022
Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials)Rubina Attar, Angie Wu, Daniel Wojdyla, et al.
Journal of Atherosclerosis and Thrombosis|March 11, 2010
Resident peritoneal inflammatory cells are pivotal in the development of experimental atherosclerosisWaldir G M Relvas, Maria C O Izar, Helena R C Segreto, et al.
American Heart Journal|March 20, 2012
A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: rationale and design of the Brazilian Intervention to Increase Evidence Usage in Acute Coronary Syndromes (BRIDGE-ACS) cluster-randomized trialOtávio Berwanger, Hélio P Guimarães, Ligia N Laranjeira, et al.
Circulation|January 19, 2021
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS TrialZiad Hijazi, John H Alexander, Zhuokai Li, et al.
Pageof 112